Robotic Genome Doctrine

Introduction

The Robotic Genome Doctrine refers to an emerging legal and ethical framework governing the use of robotic systems, artificial intelligence, and automated technologies in genomic research, genetic testing, and genome editing. It seeks to ensure that robotic technologies used to analyse, interpret, or modify genetic material remain subject to legal regulation, scientific supervision, and human accountability.

Robotic genomic technologies are increasingly important in medical diagnosis, personalised medicine, hereditary disease prevention, and biotechnology research. However, their application creates serious concerns regarding genetic privacy, informed consent, scientific reliability, biological safety, and responsibility for unintended genetic modifications.

The doctrine is based on the principle that technological advancement must not undermine human dignity, constitutional rights, or public safety. It seeks to establish a balance between scientific innovation and the protection of individuals and society.

Important Case Laws

1. Gene Campaign v. Union of India (2024), 2024 INSC 545

The Supreme Court examined the approval granted for genetically modified mustard, DMH-11. The Court held that regulatory decisions concerning genetically modified organisms are subject to judicial review. It directed the Union Government to formulate a national policy on GM crops through consultation with experts, State Governments, farmers, and other stakeholders.

SCI API+1

This case provides an important foundation for the Robotic Genome Doctrine because it emphasises scientific transparency, biosafety, public participation, and regulatory accountability.

2. Justice K.S. Puttaswamy v. Union of India (2017), (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21.

This judgment is relevant to robotic genomic systems because genetic information may reveal hereditary diseases, biological relationships, and other sensitive personal characteristics. The doctrine therefore requires protection against unlawful collection, disclosure, and misuse of genomic information.

3. Selvi v. State of Karnataka (2010), (2010) 7 SCC 263

The Supreme Court held that involuntary narcoanalysis, polygraph examinations, and brain electrical activation profile tests violate constitutional protections under Articles 20(3) and 21.

The judgment supports the principle of individual autonomy and protection against compelled scientific investigation. Its application to genomic testing is analogous and does not constitute a direct ruling on genome editing.

4. Bhabani Prasad Jena v. Orissa State Commission for Women (2010), (2010) 8 SCC 633

The Supreme Court held that DNA testing should not be ordered routinely in parentage disputes. Courts must consider necessity, privacy, dignity, and the consequences for family relationships.

This case supports the principle that genomic testing must be legally justified and proportionate to the purpose for which it is undertaken.

Legal Framework in India

India does not formally recognise a standalone statute titled the Robotic Genome Doctrine. Its principles can be developed through existing legislation and regulatory mechanisms.

Environment (Protection) Act, 1986.

Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Micro-organisms/Genetically Engineered Organisms or Cells, 1989.

Digital Personal Data Protection Act, 2023, subject to applicable provisions and commencement.

Consumer Protection Act, 2019.

Articles 14 and 21 of the Constitution.

The Department of Biotechnology's Guidelines for Safety Assessment of Genome Edited Plants, 2022, provide a specific biosafety framework for genome-edited plants.

MeitY

Core Principles of the Robotic Genome Doctrine

Human oversight: High-risk robotic genome-editing procedures must remain under qualified human supervision.

Informed consent: Individuals must understand the purpose, risks, and consequences of genomic procedures.

Genetic privacy: Genomic data must be protected against unauthorised access and disclosure.

Scientific reliability: Automated genomic results must undergo appropriate validation and verification.

Accountability: Developers, manufacturers, researchers, and institutions must be responsible according to their respective roles.

Precautionary principle: Potentially serious biological risks must be assessed before high-risk genomic activities are authorised.

Intergenerational protection: Heritable genome modifications require special ethical and regulatory scrutiny because their effects may extend to future generations.

Conclusion

The Robotic Genome Doctrine represents an emerging legal framework for regulating robotic technologies used in genetic testing, genomic research, and genome editing. Although it is not formally established as an independent doctrine under Indian law, constitutional principles, biotechnology regulations, and judicial decisions provide a foundation for its development.

The cases of Gene Campaign, Puttaswamy, Selvi, and Bhabani Prasad Jena demonstrate the importance of regulatory accountability, scientific reliability, privacy, and individual autonomy.

A comprehensive legal framework should ensure that robotic genomic technologies remain subject to human supervision, transparent regulation, and effective legal remedies. The ultimate objective is to promote scientific innovation while protecting human dignity, genetic privacy, biological safety, and the interests of future generations.